Respiratory health
A Westminster Hall debate on respiratory health is scheduled for Thursday 14 November 2024. The debate will be led by Jim Shannon MP.
On 20 October 2016, the Government announced a new funding settlement for contractors providing NHS pharmaceutical services under the community pharmacy contractual framework. Compared to 2015/16 levels, the funding settlement includes a reduction of 4% in 2016/17 and a further 3.4% in 2017/18. This briefing includes constituency data on pharmacies, including a list of those expected to be eligible for the Pharmacy Access Scheme. There will be an Opposition Day debate on community pharmacies on Wednesday 2 November 2016 in the Commons chamber.
Community Pharmacies (296 KB , PDF)
NHS England is responsible for commissioning all NHS primary care services in England, including community pharmacy services. Clinical commissioning groups (CCGs) are free to commission further services from community pharmacies over and above those commissioned by NHS England, and local authorities are able to commission public health services from pharmacies.The large majority of NHS income for community pharmacies in England comes from payment from NHS England, through the NHS pharmaceutical services contract. The NHS England funding settlement for 2014/15 and 2015/16 was £2.8 billion.
On 20 October 2016 the Government announced that contractors providing NHS pharmaceutical services under the community pharmacy contractual framework will receive:
This represents a 4% reduction in funding in 2016/17 and a further 3.4% reduction in 2017/18.
The announcement also confirmed plans for some additional funding, including:
The downloadable data file below includes a list of pharmacies in each English parliamentary constituency, along with a summary of which are expected to be eligible for the pharmacy access scheme.
For MPs and their staff, Library researchers can provide maps of pharmacies by local area like the one featured below. Please get in touch to find out more.
Community Pharmacies (296 KB , PDF)
A Westminster Hall debate on respiratory health is scheduled for Thursday 14 November 2024. The debate will be led by Jim Shannon MP.
A debate on a Motion to approve the Draft Environmental Protection (Single-Use Vapes) (England) Regulations 2024 has been scheduled in the Commons Chamber for 13 November 2024.
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab